MP18-17 KNOCKDOWN OF PD-L1 IN MOUSE RENAL CELL CARCINOMA INHIBITS TUMOR GROWTH AND IMPROVE THE ANTI-TUMOR EFFECT OF SUNITINIB
2020
INTRODUCTION AND OBJECTIVE:There are several unresolved issues regarding combined treatment with an immune checkpoint inhibitor and anti-angiogenic agent for renal cell carcinoma (RCC) patients. Th...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI